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ABSTRACT
Objectives: To investigate whether there is an
association between differences in travel time/travel
distance to healthcare services and patients’ health
outcomes and assimilate the methodologies used to
measure this.
Design: Systematic Review. We searched MEDLINE,
Embase, Web of Science, Transport database, HMIC
and EBM Reviews for studies up to 7 September 2016.
Studies were excluded that included children (including
maternity), emergency medical travel or countries
classed as being in the global south.
Settings: A wide range of settings within primary
and secondary care (these were not restricted in
the search).
Results: 108 studies met the inclusion criteria. The
results were mixed. 77% of the included studies
identified evidence of a distance decay association,
whereby patients living further away from healthcare
facilities they needed to attend had worse health
outcomes (eg, survival rates, length of stay in hospital
and non-attendance at follow-up) than those who lived
closer. 6 of the studies identified the reverse (a
distance bias effect) whereby patients living at a greater
distance had better health outcomes. The remaining 19
studies found no relationship. There was a large
variation in the data available to the studies on the
patients’ geographical locations and the healthcare
facilities attended, and the methods used to calculate
travel times and distances were not consistent across
studies.
Conclusions: The review observed that a relationship
between travelling further and having worse health
outcomes cannot be ruled out and should be
considered within the healthcare services location
debate.
INTRODUCTION
Countries, such as the UK, USA and Canada,
have been implementing a policy of centralis-
ing the care of patients for many specialised
services. There is evidence that this process
will have a positive impact on the health out-
comes of those patients treated in these spe-
cialised centres.1 2 However, there are also
drawbacks to increasing the distance some
patients travel to receive treatment. A
number of authors have documented the dis-
tance decay association, which identiﬁes that
those who live closer to healthcare facilities
have higher rates of usage after adjustment
for need than those who live further away.3 4
Indeed, as long ago as 1850 Jarvis proposed
this distance decay effect by ﬁnding that
fewer patients were admitted to a psychiatric
hospital in Massachusetts the further they
lived from that hospital.5 While there is evi-
dence of this distance decay association,
there is less evidence on how this translates
into impacts on health outcomes. Having to
travel further to access healthcare facilities
and the impact this has on patients health
require further investigation.
Strengths and limitations of this study
▪ This systematic review has, for the first time,
synthesised available evidence on the association
between differences in travel time/distance to
healthcare services and patients’ health
outcomes.
▪ It has identified a wealth of studies and gener-
ated evidence for a wide range of disease groups
and health outcomes, across multiple countries.
▪ The review found great variation in study design,
distances and travel time to access healthcare
settings, and range of health outcomes; this pre-
cluded pooling of data for a meta-analysis.
▪ While the review findings are of undoubted value
in broadening our understanding of the wider
societal factors that influence health outcomes,
their applicability may be limited to countries
with similar healthcare systems.
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A growing number of studies have determined trans-
port accessibility levels to healthcare using geographical
information system (GIS) techniques, by mapping car
and public transport travel times and distances to health-
care facilities. These can be broadly split into revealed
accessibility and potential accessibility methods, as deﬁned by
Khan.6 Revealed accessibility refers to methods that use
data from actual healthcare trips, for example, the drive
time or straight-line distance between a patient’s home
address and the hospital they attended.7 8 Potential
accessibility refers to methods that look at what is the
potential for accessing healthcare facilities in a particular
area, for example, using gravity models9 and specialised
gravity models—such as, two-step ﬂotation catchment
area method.10 11 While these methods are being widely
used and developed, the link between transport accessi-
bility to healthcare and the association of this with
patients’ health outcomes has not frequently been
considered (in part due to a lack of linked health and
transport accessibility data). The aim of this review is to
bring together studies that have calculated accessibility
(patients travel to healthcare facilities—ex-post) and
explored whether there is an associated impact from this
on health outcomes. The focus lies on whether there is
an association and the data and methods used.
METHODOLOGY
The review protocol was published in advance on the
PROSPERO database (CRD42014015162). The study fol-
lowed the PICOS (Population, Intervention,
Comparator, Outcome, Study type) search design.12 The
population were adults accessing healthcare in global
north countries (studies were included from the follow-
ing regions/countries: Northern America, Western
Europe, Australia and New Zealand). The intervention
and comparator were the distance and travel times to
healthcare. The outcomes were any health outcomes
(eg, survival, mortality and quality of life) and proxy
measures for health outcomes (eg, follow-up attendance
and usage of clinics). No restriction was made on study
type or design. We searched Web of Science, MEDLINE,
Embase, Transport database, HMIC and EBM Reviews
for relevant papers in November 2014 and updated the
search on 7 September 2016. The MEDLINE search
strategy is accessible in online supplementary material 1.
All titles and abstracts were screened by CK and 20%
independently by CH. The key inclusion criteria were
that the study quantiﬁed distance or travel time to
healthcare and identiﬁed whether there was an impact
from this on health outcomes and the assessment of
travel time/distance on the health outcome was the
primary objective of the study.
The study excluded papers:
▸ Including children (<18 years and maternity).
▸ Reporting only patient opinions and views.
▸ Reporting only one off emergency events or travel by
different types of emergency vehicles, including
myocardial infarction, and transfers between health-
care facilities.
▸ Reporting only countries classed as global south.
The full papers of studies that met the inclusion cri-
teria were reviewed by CK and CH, and data extraction
and quality assessment were completed. Reference lists
of included papers were then reviewed to identify any
additional studies. These were subjected to the same
review process described above. The quality assessment
of the studies was undertaken using a modiﬁed version
of the cohort studies, Critical Appraisal Skills
Programme (CASP) tool13 linked to the PICO terms. It
included key components of the CASP tool; for
example, did the study address a clearly deﬁned ques-
tion? Had a representative population been used? Was
the exposure (distance or travel time) accurately mea-
sured to minimise bias? And the same for the health
outcome, whether potentially confounding variables had
been identiﬁed and included in the analysis. In add-
ition, we included whether the funding source was exter-
nal to the organisation and whether the study was peer
reviewed. This was important as studies completed
in-house may have an inherent tendency to be biased.
The data were extracted and assessed for quality by CK,
according to the study protocol, and 20% were inde-
pendently extracted and assessed by CH. No studies
were excluded on the basis of the quality assessment.
RESULTS
One hundred and eight studies met the inclusion cri-
teria and were included in the review. The study ﬂow
diagram is provided in ﬁgure 1, which shows that over
13 000 abstracts were initially reviewed. The studies
covered a wide range of diseases, interventions and
health outcomes. The results of the quality assessment
Figure 1 Flow diagram of papers.
2 Kelly C, et al. BMJ Open 2016;6:e013059. doi:10.1136/bmjopen-2016-013059
Open Access
are summarised in table 1. The main area of concern
was the funding source of the study—37% of the studies
were funded in-house or it was unclear how they were
funded, which may lead to bias. However, no studies
were excluded on the basis of this assessment.
We have categorised the studies according to the follow-
ing three groups:
1. Distance decay association—studies that showed evi-
dence of an association between patients living closer
to the healthcare facility and having better health
outcomes/higher access rates to the healthcare ser-
vices compared to those living further away (see
online supplementary table S2).7 14–95
2. Distance bias association—studies that showed evidence
of an association between patients living further away
from the healthcare facility and having better health
outcomes/higher access rates to the healthcare
services compared to those living closer to the
healthcare facilities (see online supplementary
table S3).8 96–100
3. No association—those studies that found no evidence
of an association between distance from the health
facility and health outcome (see online supplemen-
tary table S4).101–119
Seventy-seven per cent of the included studies identi-
ﬁed a distance decay association; 6 studies reported a
distance bias association and 19 identiﬁed no
relationship.
The studies were diverse in nature; however, ﬁve of the
distance bias studies (see online supplementary
table S3) reported a positive relationship between
increasing travel distance and better survival rates for
patients with cancer.96 97 98 Lipe et al99 concluded that
survival rates were higher for those travelling further to
the transplant centre potentially due to referral bias, but
also for patients living further away being healthier and
more motivated. Other effects identiﬁed by the review
include the study by Kim et al42 who highlighted a
U-shaped all-cause mortality relationship. When the data
were split into three categories of distance travelled,
those in the middle (20–30 km) category had lower
all-cause mortality than those living in the closer or
further away categories. This indicated that there was
something different about this geographical area and
the people living in it. This effect was evidence in other
papers, but not at statistically signiﬁcant levels.
Over 50% of the studies reported on cancer (55% in
online supplementary table S2, 83% in online
supplementary table S3 and 53% in online
supplementary table S4), with the majority being breast
or colorectal studies. Other diseases and outcomes are
summarised in online supplementary tables S2–4. The
studies covered a wide range of contexts and travel
requirements for patients. Studies that identiﬁed a dis-
tance decay association ranged from a very localised
cohort of patients—average distances to the healthcare
facility of 21.4 km for the treatment for diabetes,71 to
>6 hours travel in Canada for breast and colorectal
cancer survival,25 to >300 km for remote kidney dialysis67
and an intercountry study with a range of 1–870 km for
treatment for malignant brain tumour.41 These differ-
ences reﬂect the geographical sizes of the countries in
question and the need to travel for specialist treatment.
There was no obvious difference in the distances and
travel times between the three groups (distance decay,
distance bias and no association).
A wide variety of methods and data (eg, registry data,
patient surveys and hospital data) were used to explore
the relationship. There were differences in the patient
origins and healthcare destinations used to determine
the patient journeys. The majority used the patients’
address (full address/postcode/zip code) as the origin
for the journey, but others used the centroids of larger
geographical areas19 34 62 90 or the referring hospital72
or the city of residence.116 It was recognised that for the
longitudinal studies, there was a potential for patients to
move addresses, but no studies used differing residential
locations where people moved house to calculate the dis-
tances and travel times. For example, Dejardin et al27
applied the residential location at the time of diagnosis
and assumed this remained constant during treatment.
Forty-eight per cent of the studies had access to data on
the nearest healthcare facility to the patient, with the
remainder using the actual healthcare facility attended.
Bristow et al20 and Henry et al107 calculated the nearest
and actual facility attended. All studies who found a dis-
tance bias association used the actual healthcare facility
attended by the patients in their study.
Table 1 Quality assessment of studies n (%)
Yes No Unclear/partial
Did the study address a clearly focused question? 108 (100%) 0 0
Was the study population recruited in an acceptable way? 105 (97.2%) 0 3 (2.8%)
Did it include all the population or describe the population not included? 97 (89.8%) 7 (6.5%) 4 (3.7%)
Was the method used to calculate the distance/travel time reported accurately? 85 (81.5%) 23 (18.5%) 0
Was the health outcome accurately measured to minimise bias? 108 (100%) 0 0
Have important confounding factors been taken account of in the design or
analysis?
90 (83.3%) 17 (15.7%) 1 (1%)
Is the funding source external to the organisation? 68 (63.0%) 16 (14.8%) 24 (22.2%)
Was the research peer reviewed? 101 (93.5%) 0 7 (6.5%)
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The methods used for calculating travel distance/
travel time in the studies ranged from straight-line dis-
tance (Euclidean distance), travel distance using a road
network (either shortest distance or shortest travel
time), travel speed using the shortest distance by road
network (with and without adjusted road network
speeds) or patients’ self-reported travel times. As pro-
vided in table 1, 19% of the studies did not clearly state
how they had calculated this variable. One hundred per
cent of the studies in the distance bias association group
calculated travel distance, 77% in the distance decay
association group and 63% in the group that identiﬁed
no association.
DISCUSSION
The results were mixed. Eighty-three studies identiﬁed
evidence of distance decay association, 19 no evidence
and 6 studies evidence of distance bias association.
Thus, the majority of studies reported a negative correl-
ation between distance/travel time to healthcare facil-
ities and health outcomes. This was true across a
multitude of disease groups, geographical distances and
boundaries. The wide range of methods, sources of data,
disease areas and outcome measures and ranges of dis-
tances travelled add to the complexity of the compari-
sons. The focus of this discussion is on the key
differences in the way that the distances and travel times
were calculated and analysed and what observations
from the studies have heightened potential reasons to
suggest an association between distance/travel time and
health outcomes.
Travelling to healthcare
The critical elements of calculating an accurate repre-
sentation of the distances and travel times that the
patients have endured require a starting location for the
journey (eg, patients’ home address),i end point
(healthcare facility) and method for accounting for the
estimated route taken between these two points. The
included studies differed on all three of these inputs.
Where the patient’s address was unavailable, less speciﬁc
geographical identiﬁers were used by the studies,
ranging from patients postcode,91 zip code centroid,29
centroid of a census district62 referral hospital,72 to the
centroid of town of residence116 to a mixture of the
above methods where data were missing at the less
aggregated geographical levels.101 Using an origin point
that is less accurate than the patient’s home address has
the potential to reduce the accuracy of the results, as it
may inﬂuence the route taken affecting the distances
and travel times.
The geographical data available for the healthcare
facilities attended also differed across studies. Fifty-two
per cent of the studies had the address of the healthcare
facility attended by the patient. The remainder used the
address of the nearest facility to the patient, as a proxy.
Knowing how realistic the proxy measure is would be a
beneﬁt, as it may dramatically change the distances/
travel times calculated. For example, Tracey et al57 identi-
ﬁed in their study that only 37% of the patients attended
the nearest facility, so using this as the proxy would
underestimate the distances travelled by patients.
Another issue identiﬁed by the studies was that where
patients were followed up over time—patients had the
potential to move home address.27 59 It was argued by
some studies that grouping distances into large categor-
ical bands allowed patients to move residence, but not
actually move categories during the study (eg,
Thompson et al,65 whereby 27% of the study’s popula-
tion changed their residence during the 5-year
follow-up, but 91% of the patients had remained in the
original distance category).
The majority of studies focused on one destination
(eg, hospital attended), for one type of treatment (eg,
an operation). This has the potential to underestimate
the impact of distance/travel times on health outcomes
—where patients are potentially making multiple trips to
a range of hospitals over the course of the year for a
range of health issues. In an attempt to be more repre-
sentative of the travel burden, Brewer et al19 used the
follow-up radiation centre address as the destination for
patients rather than the place they had the surgery, as
they argued patients would have to make this journey
more frequently. Studies such as Jones et al38 considered
the impact of a range of potential healthcare settings
(eg, distance to the nearest cancer centre, general prac-
titioner (GP) and hospital of ﬁrst referral). They found
a signiﬁcant association between distance and survival
for the GP, but not the other healthcare settings studied.
Similarly, Wang et al58 found that as travel times to the
nearest GP increased, patients were more likely to have a
later stage breast cancer diagnosis, which was not
evident when focusing on the distance to the nearest
mammography service. These examples imply that focus-
ing on a single site healthcare location (eg, hospital
where the surgery took place) could be missing the loca-
tion that most inﬂuenced the patient health outcomes.
Measuring distance and travel time
Straight-line distance was used to calculate the distance
for >25% of the studies. It is unlikely that any healthcare
trip can be made in a straight line, but it was argued by
some studies that grouping distances into categories that
covered large geographical areas reduced the effects of
differences between using road distance and straight-line
distance. The remainder of the studies calculated travel
time or road network-based distance (either shortest
route or quickest route). This was calculated in a variety
of ways, including making use of speciﬁc GIS software
(eg, ESRI ArcGIS, MAPINFO and ARCinfo), but more
recent papers had used online routing websites such as
iIt is noted that not all patient journeys start from the patient’s home
address. This is, therefore, a proxy measure.
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Google Maps, http://www.Mellisa.com or http://www.
Mapquest.com. Online resources are straightforward to
use and highly accessible to calculate distances and
travel times, but there is a question as to whether patient
data (eg, patients’ home addresses and the hospital
attended) should be uploaded to such websites and how
secure this is, especially in the case of rarer diseases. A
number of studies did take account of the time of year
to control for potential differences in the weather and
the impact this might have,101 but none included trafﬁc
congestion to calculate the travel times, which could sig-
niﬁcantly have increased the travel times included.
Distances and travel times were included in the statis-
tical models as continuous or categorical variables or
both separately. Studies identiﬁed that distances/travel
times tended to be positively skewed towards more
patients living closer to the healthcare facilities that they
were attending. To better represent this phenomenon,
Haynes et al34 split the travel times into categories
according to the lowest quartile, medium (quartiles 2
and 3), high (75–95th centile) and highest (95–100th
centile) categories. Other studies linearised distance/
travel time from the natural scale to the log scale, but
the majority did not. For studies that included distance/
travel times as a categorical variable, there was no con-
sensus on what categories should be used. Study exam-
ples include Sauerzapf et al111 who split the travel
distances into <30, 30–60 and >60 miles, Panagopoulou
et al49 used dichotomous categories < 300 and > 300 km,
Littenberg et al69 split data into < 10 and ≥ 10 km, and
Allen et al82 calculated the mean distance and used this
to split the data into two groups. Other studies used
quartiles or quintiles. In many cases, no justiﬁcation was
given for how the categories were determined, which
has the potential to hide effects, where critical thresh-
olds are missed. What the studies did identify was that
the results were sensitive to the cut-offs used in the
model. Athas et al17 found that after adjusting for age,
the likelihood of receiving radiotherapy following breast-
conserving surgery decreased signiﬁcantly with increas-
ing travel distance to the nearest facility for distances
>74 compared to <10 miles, but not for categories
in-between. In this case, a dichotomous threshold that
compared <30 and ≥30 might not have picked up this
effect. Studies may be advised to undertake sensitivity
analysis around the reference distance groups and cat-
egories used in their models—as this may greatly inﬂu-
ence the results. Abou-Nassar et al14 and Maheswaran
et al45 presented results that were only signiﬁcant in the
model that treated distance as a continuous variable;
again, the categories might not have been sensitive
enough to pick up any effect.
Mode of transport
It was assumed in the majority of studies that patients
would travel by car although there were exceptions.81 83 64
For some patients (potentially in the most deprived
groups), it will not be possible to access healthcare by
car. Moist et al64 reported that increased public transport
travel time for patients contributed to missing kidney
dialysis sessions. Jennings et al76 reported that public
transport travel times were longer for patients who did
not attend follow-up appointments compared to those
who did. Other studies included public transport access
through proxy measures (eg, whether patients were
within 800 m walking distance of an hourly bus service).
Issues with this include that it does not account for
whether the bus service identiﬁed goes to the hospital,
the travel time once on the bus or the likelihood of the
patient being able to walk 800 m. In one study, a travel
survey of patients’ trips to the hospital found that 87%
were made by car.103 To ensure representative travel
times/distance, it is critical to understand the patient
population (in this case how they are travelling).
Key relationships
The studies in the review highlight some of the key
factors that were found to be more sensitive to the dis-
tance decay effect. For example, Joseph and Boeckh80
identiﬁed that the distance decay effect was more pro-
nounced for less serious illnesses and Arcury et al83 iden-
tiﬁed that patients attended signiﬁcantly more regular
check-up care visits the shorter the distance to the facil-
ity. While, for Lara et al,77 distance was a predictive factor
for not attending in-between follow-up appointments (6
and 9 months), whereas it was not predictive for the
12-month or 3-month follow-up appointments following
a gastric band being ﬁtted. These studies all suggest that
when patients feel the health situation is more serious or
they live closer they are more likely to attend. In their
study, Abou-Nassar et al14 found that the impact of dis-
tance on health outcomes was only signiﬁcant 1 year
after a transplant, suggesting that the point at which the
health outcome and distance is measured could be crit-
ical to the results. Lake et al91 identiﬁed that while there
was an effect of distance on patients attending treatment
for tuberculosis (TB), when doing subgroup analysis this
was only signiﬁcant for those patients not native to the
country, so potentially identifying an impact of reduced
ability to travel for patients who are less familiar with the
healthcare system and transport network. All of which
could be considered when tailoring healthcare provision
and require further research.
One of the key inﬂuencing variables identiﬁed by the
studies was deprivation. Dejardin et al27 found that when
controlling for deprivation that the effect of distance on
health outcomes was removed, whereas Crawford et al26
observed that distance ampliﬁed the effect from depri-
vation. From one side, it might be argued that by con-
trolling for deprivation, this is also removing some of
the impact of distance/time that is experienced by those
who do not have access to a car and would have to travel
by other means. For those studies in the review, not con-
trolling for deprivation may be overestimating the true
impact of distance travelled/travel time on patient’s
health.
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Studies such as those in online supplementary table S3
(distance bias association) show that, in some cases,
patients are capable of travelling longer distances and
have better health outcomes than those living closer. This
indicates that there are factors other than distance (such
as deprivation) that are contributing to how easily
patients can travel to access the healthcare facilities.
Differences in distances that patients would be willing to
travel (travel thresholds) to the primary care practice
have been explored in studies such as McGrail et al120
who asked patients “what would be the maximum dis-
tance they would be willing to travel to access their GP?”
(for a non-emergency). Communities where the popula-
tion was sparsely located were found to be willing to travel
a maximum of 22.2 minutes more to visit the primary
care practice than those in closely settled communities.
Buzza et al found that distance was the most important
barrier to accessing healthcare in their study, but also
identiﬁed “health status, functional impairment, travel
costs and work or family obligation” as key barriers (ref.
121, p. 648). Similarly, the Social Exclusion Unit (SEU)
in the UK proposed that a person’s ability to travel was
inﬂuenced by key factors, including their travel horizons
(where are they willing to travel to?, what maximum dis-
tance? and do they have full awareness of available trans-
port options for the journey), Cost (can they afford to
travel to the healthcare facility?), Physical Access (their
health state may make accessing transport physically difﬁ-
cult or if accessing public transport, there may not be an
appropriate route) and Crime (they may not want to travel
unless they felt safe making the journey) SEU.122 All
these factors need to be considered when focusing on
where to locate a healthcare facility/improve access for
patients to an existing facility and ultimately improve
health outcomes. For studies such as Bristow et al,96 closer
investigation of those patients living, <5 km from the hos-
pital whose health outcomes were worse than those living
further away, or in the case of Kim et al42 what makes
those patients living 20–30 km away have better health
outcomes—what makes them different? And how can
these other groups be better supported to access health-
care services? Using the types of studies brought together
in this review allows some of these questions to be
explored and inform debate over potential solutions.
The reason for undertaking this review was to collate
and review evidence on the potential impact of distance
and travel time to healthcare on patients’ health out-
comes. This is particularly pertinent given the move to
centralised specialist services, which typically mean
increased travel distance to access those healthcare facil-
ities. Studies such as Kerschbaumer et al41 have shown
that if follow-up can be completed successfully at a local
level (even if the surgery is centralised), this can
improve health outcomes and reduced travel burden.
The review has shown that by making use of ex-post
healthcare data, providers can identify spatially pockets
of patients who would be disadvantaged through having
to travel further to access healthcare facilities and could
use this to examine how these patients match with exist-
ing support and transport networks. It has also shown
that it is not just about identifying patients who have to
travel the furthest with evidence of patients living in
close proximity to the healthcare facilities often fairing
the worst. More research is needed to pick up on these
factors and to explore in more detail the impact that the
methods and data sources have on the results.
Strengths and limitations
This systematic review has, for the ﬁrst time, synthesised
available evidence on the association between differ-
ences in travel time/distance to healthcare services and
patient’s health outcomes. It has identiﬁed a wealth of
studies and generated evidence for wide range of
disease groups and health outcomes, across multiple
countries. There was great variation in study design, dis-
tances and travel times to the healthcare setting, and the
range of health outcomes; this precluded pooling of
data for meta-analysis. The study followed a search strat-
egy to maximise the identiﬁcation of relevant studies; of
which, 19 did not ﬁnd an association between distance/
travel time and health outcomes; this is likely to be an
underrepresentation if authors have a tendency to not
publish results that showed no effect. While the review
ﬁndings are of undoubted value in broadening our
understanding of the wider societal factors that inﬂu-
ence health outcomes, their applicability may be limited
to countries with similar healthcare systems.
CONCLUSIONS
In the debate between local versus centralised health-
care provision, 77% of the included studies showed evi-
dence of an association between worse health outcomes
the further a patient lived from the healthcare facilities
they needed to attend. This was evident at all levels of
geography—local level, interurban and intercountry
level. A distance decay effect cannot be ruled out, and
distance/travel time should be a consideration when
conﬁguring the locations of healthcare facilities and
treatment options for patients.
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